• Skip to primary navigation
  • Skip to main content
  • Skip to footer
Gynecologic Oncology

Gynecologic Oncology

  • Contact Us
  • 888-GYNONC1

GYN 104 AVB500-OC-004

Advanced Ovarian Cancer: Platinum resistant

A Phase 3, Randomized, Double-Blind, Adaptive, Placebo/Paclitaxel-Controlled Study of AVB-S6-500 in Combination with Paclitaxel in Patients with Platinum-Resistant Recurrent Ovarian Cancer (AXLerate-OC)

Cancer Types: GYN, Ovarian

Lines of Therapy: 2nd Line Metastatic, 3rd Line+ Metastatic

View Details on ClinicalTrials.gov

Back to Clinical Trials

Footer

 

To schedule an appointment:

888-GYNONC1

 

Copyright © 2025 Gynecologic Oncology